The management of relapsed and refractory multiple myeloma (RRMM) continues to be challenging though new therapeutics for the disease have been emerging in recent decades. Essentially, while decreased survival was observed in each extra line of ther...

Therapeutic Sequencing Strategy in Multiple Myeloma Date: 24 th June 2021 (Thursday) Time: 19:00 - 20:40 (GMT+8, HKT) Meeting format: Zoom meeting Address: Salon Room III, Hyatt Regency Hong Kong, 18 Hanoi Road, Tsim Sha Tsui, Kowloon The survival o...

Breast cancer ranks the first place among female cancers in Hong Kong, with the incidence increased nearly 4 times within the past 25 years. Although a wide spectrum of therapies for breast cancer is currently available, the prognosis of the disease...

Over the past 25 years, significant progress has been made in the treatment of multiple myeloma (MM) as reflected by the improved overall survival (OS). However, in relapsed and refractory MM (RRMM), median OS decreases with each extra line of thera...

The Live Symposium on Breast Health Education 2021 Breast cancer is the most common cancer among women both globally and locally, whereas the number of locally diagnosed female breast cancer cases has increased by 4 times from 1993 to 2018. This ind...

The Uro-Oncology Asia 2021 Significant advances in urological cancer treatments have been emerging in recent years. For instance, immunotherapy continues to play an increasingly important role and innovations in biomarkers help select patients for s...

Management of Relapsed and Refractory Multiple Myeloma Date: 25 February 2021 (Thursday) Time: 19:15 - 20:40 (GMT+8, HKT) Meeting format: Zoom meeting Webinar on Management of Relapsed and Refractory Multiple Myeloma Multiple myeloma (MM) is charact...

Since June 2020, a webinar series known as Guerbet APAC TV so far has reached 81 countries/regions worldwide since it has been broadcasted. This year their 6 live webinars cover various topics in diagnostic imaging such as the application of artif...